Fovista®

• Business
• Management
• Pharma & Biotech
• Switzerland

Novartis signed licensing agreement with Ophthotech Corporation to market Fovista® outside the United States

Novartis acquires exclusive ex-US rights to Fovista from Ophthotech; upfront payment of USD 200 million plus potential future recruitment and…